Exceptional response to nivolumab of a heavily pre-treated patient with metastatic renal-cell cancer: from a case report to molecular investigation and future perspectives

Exceptional response to nivolumab of a heavily pre-treated patient with metastatic renal-cell cancer: from a case report to molecular investigation and future perspectives

Immunotherapy may result in long-lasting exceptional clinical responses, the molecular background of which is inadequately understood. Here, we present the case of a 63-year-old patient with a past medical history of renal cancer who relapsed many years later. Several treatment lines were administer...

Full description

Bibliographic Details
Main Authors: Foteinos-Ioannis D. Dimitrakopoulos, Eleni Kourea, George Nasioulas, Eirini Papadopoulou, Achilles Nikolakopoulos, Despoina Spyropoulou, Anastasia Kottorou, Andreas Karatzas, Haralabos P. Kalofonos, Angelos Koutras
Format: Article
Language:English
Published: SAGE Publishing 2020-08-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758835920946152

Similar Items

Similar Items